The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...

Beacon Therapeutics Holdings Limited ('Beacon Therapeutics' or 'the Company'), a leading ophthalmic gene therapy company with ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

New gene editing methods have been introduced in the country, bringing new hope to couples who tested positive for certain ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

The gene therapy improved motor functions in children with Duchenne muscular dystrophy two years after treatment ...

Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys for ...

Research continues in this field of precision oncology and there has been an explosion of novel drugs in this field ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigati ...

Louise Digby, vice president of enzymes and bioproduction at BioProduction by SEKISUI, discusses some of the current ...

“So much of our addiction treatment is actively traumatic,” Szalavitz told Salon in a phone interview. “It tells people, ‘Sit ...